Author: Dino Mustafić

February 27, 2024 Off

Akeada, Biological E. Limited in partnership to hasten access to dengue vaccine

By Dino Mustafić

A strategic partnership between Akeada and Biological E. Limited aims to hasten access to QDENGA® (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) multi-dose vials (MDVs) for National Immunization Programs by 2030. MDVs offer cost and logistical benefits, with BE aiming for a manufacturing capacity of 50 million doses yearly to support Takeda’s goal of 100 million doses annually within the decade.

January 11, 2024 Off

Mainz Biomed N.V. strengthens partnership with TestDNA to advance colorectal cancer detection in Poland

By Dino Mustafić

Mainz Biomed N.V., a company focused on molecular genetics diagnostics for early cancer detection, is confirming its collaboration with TestDNA at the forthcoming 10th Gdańsk Gastroenterology Symposium scheduled for January 12th–13th, 2024. The joint effort aims to progress the detection of colorectal cancer (CRC) in Poland, with a focus on introducing innovative approaches that can improve treatment choices and elevate survival rates through early identification of the disease.